PRESS RELEASE published on 09/22/2025 at 19:06, 1 year 1 month ago Attestation de la personne responsable associée au rapport d'activité et financier semestriel 2025 Attestation de conformité des comptes consolidés pour le semestre écoulé de GEIXIFIT. Pascal Prigent, Directeur Général, certifie l'image fidèle du patrimoine et des activités de l'entreprise Comptes Consolidés Conformité Attestation GEIXIFIT Pascal Prigent
PRESS RELEASE published on 09/22/2025 at 19:02, 1 year 1 month ago Rapport des CAC associé au rapport d'activité et financier semestriel 2025
BRIEF published on 09/19/2025 at 22:15, 1 year 1 month ago GENFIT recentre le développement de VS-01 sur une nouvelle pathologie Biopharmaceutique GENFIT ACLF VS-01 UCD
BRIEF published on 09/19/2025 at 22:15, 1 year 1 month ago GENFIT refocuses the development of VS-01 on a new pathology Biopharmaceutical GENFIT ACLF VS-01 UCD
PRESS RELEASE published on 09/19/2025 at 22:10, 1 year 1 month ago GENFIT Announces Discontinuation of its VS-01 Program in ACLF: VS-01 Development Refocused on UCD GENFIT discontinues VS-01 program in ACLF and shifts focus to UCD due to safety concerns. The company aims to accelerate other assets in ACLF, while exploring CCA data and reducing operating expenses Clinical Trials GENFIT ACLF VS-01 UCD
PRESS RELEASE published on 09/19/2025 at 22:10, 1 year 1 month ago GENFIT annonce l'arrêt de son programme VS-01 dans l'ACLF – le développement de VS-01 est recentré sur l'UCD GENFIT annonce l'arrêt de son programme VS-01 dans l'ACLF et se recentre sur l'UCD pour traiter les troubles du cycle de l'urée. L'arrêt fait suite à un événement indésirable grave dans l'essai clinique UNVEIL-IT® GENFIT ACLF VS-01 UCD Troubles Du Cycle De L'urée
BRIEF published on 07/08/2025 at 22:15, 1 year 3 months ago GENFIT Reports on Half-Year Liquidity Contract with Crédit Industriel et Commercial Biopharmaceutical Liver Diseases Crédit Industriel GENFIT Liquidity 2025 Trading
BRIEF published on 07/08/2025 at 22:15, 1 year 3 months ago GENFIT annonce son contrat de liquidité semestriel avec le Crédit Industriel et Commercial Biopharmaceutique Crédit Industriel Maladies Du Foie Liquidité De GENFIT Négociations 2025
PRESS RELEASE published on 07/08/2025 at 22:10, 1 year 3 months ago Genfit : Bilan semestriel du contrat de liquidité contracté avec le Crédit Industriel et Commercial GENFIT annonce le bilan semestriel de son contrat de liquidité avec le Crédit Industriel et Commercial, incluant les transactions et moyens de liquidité au 30 juin 2025 Contrat De Liquidité Bilan Semestriel Transactions Crédit Industriel Et Commercial GENFIT
PRESS RELEASE published on 07/08/2025 at 22:10, 1 year 3 months ago Genfit: Half-Year Report of Liquidity Contract with Crédit Industriel et Commercial GENFIT announces half-year report of liquidity contract with Crédit Industriel et Commercial, detailing trading activities and resources as of June 30, 2025 Liquidity Contract Financial Report Crédit Industriel Et Commercial Trading Activities GENFIT
Published on 10/30/2026 at 23:35, 1 day 18 hours ago Prospect Ridge Announces Closing of Critical Metals Flow-through Unit Private Placement
Published on 10/30/2026 at 23:30, 1 day 18 hours ago Revolve Enters into Definitive Agreement to Acquire Three Project, 6 MW Battery Storage Portfolio in Ontario
Published on 10/30/2026 at 19:00, 1 day 23 hours ago Electric Royalties Ltd. Announces Application for Warrant Extension
Published on 10/30/2026 at 15:30, 2 days 2 hours ago Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split
Published on 11/01/2026 at 10:35, 7 hours 46 minutes ago Shenzhen Unveils APEC China 2026 Host-City Theme Song and Music Video
Published on 11/01/2026 at 05:00, 13 hours 21 minutes ago 2026 Yangtze River Culture Festival Opens in Yonglian Village, Zhangjiagang, Jiangsu
Published on 10/31/2026 at 16:35, 1 day 1 hour ago SKYWORTH Solar Announces Global Launch of Solavita as a Smart Microgrid Brand
Published on 10/30/2026 at 22:49, 1 day 19 hours ago EQS-Adhoc: STRATEC SELLS LOSS-MAKING BUSINESS, RECOGNIZES IMPAIRMENTS, AND AMENDS GUIDANCE
Published on 10/30/2026 at 23:00, 1 day 19 hours ago BIOPHYTIS REPORTS FIRST- HALF 2026 RESULTS AND PROVIDES AN UPDATE ON ITS STRATEGY
Published on 10/30/2026 at 23:00, 1 day 19 hours ago Biophytis publie les résultats du premier semestre 2026 et fait le point sur sa stratégie